Key Takeaways
- AstraZeneca (AZN) advances its oral GLP-1 drug, Elecoglipron, to Phase III trials after mid-stage data showed weight loss of up to 11.8%, positioning the firm to challenge leaders in the $5 billion obesity market.
- FedEx (FDX) raised its annual dividend by 5% to an annualized rate of $4.88 following the successful spin-off of its Freight division, signaling strong post-restructuring confidence.
- The Nasdaq (IXIC) gained 0.85% to close at 25,928.93, buoyed by news of an Apple (AAPL) and Google (GOOGL) AI partnership, while the Dow Jones (DJI) slipped 0.17%.
- Geopolitical risks intensified as the Iranian Revolutionary Guard launched strikes in Northern Iraq, coinciding with reports that Donald Trump warned Israel it could be "left alone" if it escalates conflict with Iran.
- Nvidia (NVDA) CEO Jensen Huang declined a request from Senator Elizabeth Warren to testify at a Senate hearing regarding the company's AI operations and export policies in China.
Market Overview: Tech Leads as Dow Lags
US equity markets finished the day with mixed results as investors weighed positive developments in the technology and pharmaceutical sectors against rising geopolitical uncertainty. The Nasdaq (IXIC) rose 219.49 points (0.85%) to close at 25,928.93, while the S&P 500 (SPX) edged up 0.32% to 7,407.70. Conversely, the Dow Jones Industrial Average (DJI) fell 84.82 points (0.17%) to finish at 50,781.96, reflecting a rotation out of traditional blue-chip stocks.
AstraZeneca Targets Obesity Market with Phase III Advancement
AstraZeneca (AZN) shares saw positive momentum after the company announced it is moving its oral GLP-1 receptor agonist, Elecoglipron (AZD5004), into Phase III clinical trials. Data from the VISTA and SOLSTICE Phase IIb trials demonstrated that the once-daily pill achieved a 10.5% to 11.8% reduction in body weight over 26 to 36 weeks. Analysts suggest this oral alternative could significantly disrupt the weight-loss market currently dominated by injectable treatments.
FedEx Boosts Shareholder Returns Post-Spin-Off
FedEx (FDX) announced a 5% increase in its annual dividend rate, setting the new annualized payout at $4.88 per share. The move follows a one-time adjustment related to the spin-off of FedEx Freight, which began trading as an independent entity on June 1. The quarterly dividend of $1.22 per share is payable on July 7 to stockholders of record as of June 22, 2026.
AI Alliances and Regulatory Friction
Apple (AAPL) and Alphabet (GOOGL) are reportedly deepening their collaboration to integrate Google Gemini technology into Apple Intelligence. While the partnership aims to bolster Siri's capabilities, Apple is still navigating strict regulatory hurdles in China to gain approval for its AI suite. The tech sector also faced political scrutiny as Nvidia (NVDA) CEO Jensen Huang officially declined an invitation from Senator Elizabeth Warren to testify before the Senate Banking Committee regarding AI chip exports.
Geopolitical Tensions in the Middle East
Regional stability in the Middle East remains precarious following reported explosions in Sulaymaniyah, Northern Iraq, which the Iranian Revolutionary Guard confirmed were strikes against Kurdish opposition groups. Adding to the tension, journalist Barak Ravid reported that Donald Trump warned Prime Minister Benjamin Netanyahu that Israel might have to fight "alone" if it returns to a full-scale war with Iran. These developments have kept energy markets on edge and contributed to the Dow's cautious performance today.
Aviation: WestJet Opposes Federal Loan Program
In Canada, WestJet has voiced strong opposition to a federal government proposal offering up to C$150 million in repayable loans to airlines struggling with high fuel costs. The airline urged Ottawa to avoid "market distortions" and criticized the move as a form of corporate subsidy that could disadvantage carriers with leaner operations. Meanwhile, Rio Tinto (RIO) highlighted its long-term commitment to the region, noting that its Canada Fund has now invested nearly C$190 million across 600 organizations since 2008.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.